Infrastructure major Larsen & Toubro (L&T) reported a 3 per cent year-on-year decline in consolidated net profit for Q4 FY26, reaching 5,325.60 crore, primarily due to exceptional gains in the previous year. Despite this, the company's consolidated order book surged by 28 per cent to 7.4 trillion, with international orders accounting for 52 per cent.
Infosys Q4 results beat estimates, but weak FY27 guidance triggers cautious brokerage outlook and target price cuts. Should investors worry?
Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the fourth quarter ended March 31, 2025. The Mumbai-based drug firm had reported a consolidated net profit of Rs 939 crore for the January-March period a year ago.
Private sector lender Yes Bank reported a 45 per cent increase in its March quarter net profit to Rs 1,068 crore, with its new managing director and CEO, Vinay M. Tonse, signalling the end of its over six-year-long recovery phase and a readiness to align loan growth with the broader banking sector.
State Bank of India (SBI) on Saturday reported 10 per cent fall in standalone net profit at Rs 18,643 crore for the fourth quarter ended March 2025. The country's biggest lender had earned a profit of Rs 20,698 crore in the January-March period of 2023-24.
Reliance Industries is expected to report largely flat performance for its fourth quarter (January-March, Q4) of FY26, with weakness in the oil-to-chemicals (O2C) business and muted retail growth likely to offset steady gains in the telecommunications segment.
State-owned insurer Life Insurance Corporation of India (LIC) on Tuesday posted a 38 per cent increase in net profit to Rs 19,013 crore in the fourth quarter ended March 2025 helped by lower expenses. The country's biggest insurer had earned a profit of Rs 13,763 crore in the corresponding quarter a year earlier.
ICICI Bank reported a 9.28 per cent increase in its consolidated net profit to Rs 14,755 crore for the March quarter of FY26, primarily driven by a nearly 90 per cent reduction in provisioning. The bank's executive director, Sandeep Batra, noted strong asset growth but expressed caution regarding the geopolitical situation in West Asia.
API Holdings, the parent company of online pharmacy PharmEasy, has significantly reduced its debt from 1,800 crore to 1,050 crore and refinanced it at lower interest rates under CEO Rahul Guha, shifting its focus from 'growth at any cost' to profitability and aiming for a debt-free balance sheet before a potential stock market listing.
India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.
Reliance Industries Ltd on Friday reported a 2.4 per cent rise in its March quarter net profit as store rationalisation in retail business and improved margins in telecom helped offset weakness in mainstay oil and petrochemicals business and higher finance cost. Consolidated net profit of Rs 19,407 crore, or Rs 14.34 per share, in January-March - the fourth quarter of April 2024 to March 2025 fiscal (FY25) - was higher than Rs 18,951 crore, or Rs 14 a share, in the same period a year back, the company said in a statement.
IndiGo, India's largest airline, reported a net loss of Rs 2,536.9 crore in the March quarter of fiscal year 2025-26, primarily attributed to a significant foreign exchange loss of approximately Rs 8,100 crore, the impact of December flight disruptions, and expenses related to new labour laws.
Indian hotel companies are experiencing a sharp correction in share prices due to the Iran war and broader geopolitical tensions, leading analysts to cut operating profit expectations and valuations, despite structurally positive medium-term prospects.
The country's largest lender SBI on Thursday reported 18.18 per cent growth in March quarter consolidated net profit to Rs 21,384.15 crore as against Rs 18,093.84 crore in the year-ago period. On a standalone basis, profit grew to Rs 20,698.35 crore from Rs 16,694.51 crore a year ago, the lender said in a regulatory filing.
The remarkable rise of smallcaps reflects the emergence of a broad set of specialised businesses operating in industries where the sectoral tailwinds remain considerably stronger than macroeconomic headwinds, points out Debashis Basu.
Hero MotoCorp on Tuesday posted 24 per cent increase in consolidated profit after tax at Rs 1,169 crore for the fourth quarter ended March 31, 2025 riding on higher margins backed by better product mix, parts revenue and cost effectiveness. The company had reported a consolidated profit after tax (PAT) of Rs 943 crore in January-March FY24.
Torrent Pharma has emerged as a top sectoral pick for brokerages, driven by healthy growth in India revenues and improved gross margins, leading to a 44 per cent stock return over the past year.
Telecom operator Bharti Airtel posted about a five-fold jump in consolidated net profit to Rs 11,022 crore in the March 2025 quarter, mainly due to the tariff hike impact and one-time gain on tax benefits. Bharti Airtel had posted net profit (attributable to owners of the parent company) of Rs 2,071.6 crore a year ago.
InterGlobe Aviation (IndiGo) is experiencing significant financial pressure, with its stock falling 18 per cent since the start of the Iran war, due to rising Brent crude prices, a weakening rupee, and disruptions to its West Asia and European flight networks caused by geopolitical tensions.
Indian paint majors, including Asian Paints, Berger Paints, and Kansai Nerolac, reported better-than-expected performance in Q4FY26, driven by steady demand, improved product mix, and strategic price hikes. The sector is also benefiting from reduced competitive intensity as new players also increase prices, narrowing the gap with incumbents.
India's second-largest telecom operator Bharti Airtel on Tuesday posted more than twofold year-on-year jump in its consolidated net profit for the March quarter to Rs 2,008 crore, buoyed by a lift in average revenue per user and an exceptional gain. The telco said its Q4 scorecard was backed by strong performance delivery across the portfolio and its CEO Gopal Vittal, in a statement, exuded optimism about opportunities in the coming years and Airtel being "well-poised" as a company. Airtel, which competes in the market with Reliance Jio and Vodafone Idea, as well as state-owned BSNL/MTNL, promised to maintain razor sharp focus on financial flexibility, optimising the capital structure and finance cost.
Sun Pharmaceutical Industries reported strong consolidated numbers for Q4 FY26, with net profit rising 26 per cent year-on-year to 2,714 crore, despite continued weakness in its US generics business. Growth in innovative medicines and increased R&D investments are helping to offset these pressures.
Shares of Avenue Supermarts, operator of DMart, fell 5.2 per cent after reporting mixed Q4 FY26 results, with brokerages offering divergent 'sell', 'buy', and 'hold' ratings based on factors like valuation, competitive intensity, and store expansion strategies.
Mphasis BFL has reported a 23 per cent jump in consolidated net profit to Rs 30.96 crore (Rs 309.6 million) for the quarter ended March 31, 2005 as compared to Rs 25.12 crore (Rs 251.2 million) for the quarter ended March 31, 2004.\n
Despite a disappointing Q4 FY26 performance, many analysts remain bullish on Hindustan Aeronautics (HAL) due to its substantial order book and pipeline. However, persistent supply chain issues, particularly for jet engines, and execution challenges are key factors that could impact its future stock performance and revenue growth.
Bharat Forge reported modest Q4FY26 results but provided strong guidance, anticipating significant growth from its defence, aerospace, and data centre segments, with a projected 25 per cent revenue growth in Indian manufacturing for FY27, despite current high valuations.
India's second-largest IT company Infosys on Thursday reported an 11.7 per cent decline in consolidated net profit to Rs 7,033 crore for the March quarter. It had posted a profit (attributable to owners of the company) of Rs 7,969 crore in the year-ago period.
State-run Bharat Petroleum Corporation Ltd (BPCL) plans a significant capital expenditure of 25,000 crore for the financial year 2026-27, primarily for ongoing expansion projects. The company also stated that the recent 4-per-litre price hike in petrol and diesel has provided some financial relief amidst volatile crude oil prices and mounting losses.
Godrej Properties Limited (GPL) reported its highest-ever quarterly profit of 649.5 crore in Q4 FY26, a 70.13 per cent year-on-year increase, driven by record revenues and bookings. The company aims for over 39,000 crore in residential bookings for FY27 and plans to raise up to 3,000 crore through debt securities.
Godrej Consumer Products Ltd (GCPL) delivered a robust Q4FY26 performance, with steady demand in India and signs of stabilisation in international markets, despite persistent inflationary pressures. The company expects to maintain profitability in FY27 through strategic cost management and pricing adjustments.
Yes Bank on Saturday reported over two-fold jump in standalone net profit at Rs 452 crore for March quarter 2023-24, primarily due to benefits on the provision front. In the year-ago quarter, the bank logged a profit of Rs 202.43 crore. The private sector lender benefitted from write-back on income tax and interest on income tax returns, but the profits were limited by its inability to comply with the mandatory priority sector lending (PSL) requirements, its management said.
Shares of power generation-related companies surged on Wednesday, with the BSE Power index hitting a new high of 8,497, driven by strong demand, robust order books, and significant capital expenditure announcements from key players like Hitachi Energy India, Adani Green Energy, and CG Power and Industrial Solutions.
InterGlobe Aviation, the parent of the country's largest airline IndiGo, on Wednesday posted its highest ever fourth-quarter profit after tax of Rs 3,067.5 crore, mainly helped by strong air travel demand. The company's profit after tax in the three months ended March 2025 jumped 62 per cent from Rs 1,894.8 crore in the year-ago period.
Hindustan Unilever (HUL) exceeded consensus estimates in Q4FY26, driven by lower overheads and 6 per cent consolidated volume growth. However, the company anticipates further price hikes to counter an expected 8-10 per cent material cost inflation, while maintaining a mid-term margin guidance of 22.5-23.5 per cent.
FMCG major Hindustan Unilever on Wednesday reported a 1.53 per cent decline in consolidated net profit to Rs 2,561 crore for the fourth quarter ended March 31, 2024 due to factors such as deflation and softening of commodity prices. The company had posted a net profit of Rs 2,601 crore in the year-ago period, according to a regulatory filing from HUL. Net sales of Hindustan Unilever Ltd (HUL) were almost flat to Rs 15,013 crore in the March quarter.
Indian stock markets are set to be influenced by ongoing developments in the US-Iran conflict, fluctuations in crude oil prices, and the latest quarterly earnings reports from major corporates, with foreign investor activity also playing a crucial role.
Nomura has increased its March 2027 target for the Nifty 50 to 25,900, driven by strong corporate earnings and attractive market valuations, even as risks from the West Asia conflict and high oil prices persist.
Fintech giant One97 Communications, which operates Paytm, has decided against applying for a Non-Banking Financial Company (NBFC) licence, favouring its existing partnership model.
Global financial institutions, including Goldman Sachs and Citigroup, have invested Rs 963 crore in One 97 Communications (Paytm's parent company) through open market transactions, acquiring a 1.34 per cent stake from SAIF Partners and Elevation Capital.
Indian pharmaceutical companies are strategically increasing investments in the US market, focusing on specialty drugs, complex generics, respiratory products, and local manufacturing, despite a nearly 10 per cent fall in exports to the US in FY26 due to pricing pressure and competition in traditional generics.
